Abstract
THE therapeutic indications for œstriol have, until now, been limited to the treatment of superficial conditions of the cervix, vagina and vulva, and to the relief of menopausal symptoms. At the dosage-level effective in these cases, œstriol has no effect on the endometrium and does not, therefore, lead to irregularities in the menstrual cycle or to uterine hæmorrhage.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
POLIWODA, H. Treatment of Thrombocytopænic Hæmorrhage with Œstriol Succinate. Nature 191, 400 (1961). https://doi.org/10.1038/191400a0
Issue Date:
DOI: https://doi.org/10.1038/191400a0
This article is cited by
-
Oestrogene in der Augenheilkunde
Albrecht von Graefe's Archive for Clinical and Experimental Ophthalmology (1968)
-
Zur Frage einer h�mostyptischen Wirkung von Oestriolsuccinat im Rahmen der Anticoagulantientherapie mit Cumarinderivaten
Archiv f�r Gyn�kologie (1968)
-
Oestrogene, Gef��e und h�morrhagische Diathesen
Archiv f�r Gyn�kologie (1965)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.